Sign In
test

ZACHARY CANONICO

Diadema Partners Lp

Assets Managed
$587.737M
Holdings
111
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
1.24%(2Q avg: 24.87%)
Sustained Growth
3 quarters

Portfolio positions

This chart displays the top 10 holdings in Diadema Partners Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 111 positions.

Assets under management

The assets under management (AUM) of Diadema Partners Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 587.737M in assets, with a quarterly growth rate of 1.24% and a 2-quarter average growth rate of 24.87%. The portfolio is managed by ZACHARY CANONICO, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
UTHR
United Therapeutics Corp
Recent Activity
Increased 775.03%
8.83%
$51.888M↓ Put
87,503 shares@ $592.99 avg price
VRTX
Vertex Pharmaceuticals Inc
Recent Activity
Decreased -1.38%
7.37%
$43.288M
96,940 shares@ $446.55 avg price
VKTX
Viking Therapeutics Inc
Recent Activity
Decreased -11.77%
6.56%
$38.54M
1.184M shares@ $32.55 avg price
CAPR
Capricor Therapeutics Inc
Recent Activity
Increased 53.88%
5.34%
$31.359M↑ Call
1.032M shares@ $30.4 avg price
ABVX
Abivax Sa-adr
Recent Activity
Increased 264.8%
5.19%
$30.487M
275,944 shares@ $110.49 avg price
LQDA
Liquidia Corp
Recent Activity
Increased 3154.43%
4.58%
$26.875M↑ Call
712,100 shares@ $37.74 avg price
RVMD
Revolution Medicines Inc
Recent Activity
Increased 457.47%
3.42%
$20.07M
206,372 shares@ $97.25 avg price
APGE
Apogee Therapeutics Inc
Recent Activity
Increased 5.41%
3.19%
$18.728M↑ Call
222,500 shares@ $84.17 avg price
ur-1⤦
Bridgebio Pharma Inc
Recent Activity
New Position
3.16%
$18.565M
250,000 shares@ $74.26 avg price
INCY
Incyte Corp
Recent Activity
Increased 83.43%
2.94%
$17.264M↓ Put
183,429 shares@ $94.12 avg price

1-10 of 111